Stage III-IV / extranasal involvement / PINK-E score ≥3 — favor SMILE intensive regimen +...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-NK-T-NASAL-HIGH-RISK-BIOLOGY |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-NK-T-NASAL |
| Sources | SRC-ESMO-PTCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Stage III-IV / extranasal involvement / PINK-E score ≥3 — favor SMILE intensive regimen + radiotherapy over reduced-intensity DDGP-mod/AspaMetDex. |
|---|---|
| Clinical direction | investigate |
| Category | high-risk-biology |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "ann_arbor_stage",
"threshold": 3
},
{
"comparator": ">=",
"finding": "pink_e_score",
"threshold": 3
},
{
"finding": "extranasal_involvement",
"value": true
}
],
"type": "composite_score"
}
Notes
PINK / PINK-E (Prognostic Index NK lymphoma) plus stage drives intensity selection. SMILE has CR rates >70% in advanced disease; less intensive regimens trail by 15-20%.
Used By
No reverse references found in the YAML corpus.